871
Views
7
CrossRef citations to date
0
Altmetric
Letter

An Exceptional Case of Full-thickness Macular Hole Closure in a Patient with Behçet Disease

, MD, , MD, , Prof MD, , MD & , MD
Pages 79-81 | Received 16 Dec 2012, Accepted 29 Apr 2013, Published online: 24 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Zohreh Ebrahimi, Ali Torkashvand, Mohammad Zarei, Hooshang Faghihi, Elias Khalili Pour, Marjan Imani Fooldi & Nazanin Ebrahimiadib. (2022) Treatment of Inflammatory Macular Hole: Case Series and Review of Literature. Ocular Immunology and Inflammation 30:4, pages 966-972.
Read now

Articles from other publishers (6)

A. Bennis, F. Chraibi, M. Abdellaoui & A.I. Benatiya. (2022) Macular hole in Behçet's disease: Contribution of multimodal imaging. Journal Français d'Ophtalmologie 45:10, pages 1217-1218.
Crossref
Mohamed Kamel Soliman, Dalia M. Tohamy, Ahmed B. Sallam, Tarek Tabbaa & Shree K. Kurup. (2022) Treatment outcomes of macular holes in the setting of uveitis: a scoping review. Graefe's Archive for Clinical and Experimental Ophthalmology 260:7, pages 2079-2086.
Crossref
Devesh Kumawat, Pradeep Venkatesh, Anand S. Brar, Pranita Sahay, Vinod Kumar, Parijat Chandra & Rohan Chawla. (2019) ATYPICAL MACULAR HOLES. Retina 39:7, pages 1236-1264.
Crossref
Natalia F. CallawayMarco A. GonzalezYoshihiro YonekawaLisa J. FaiaEfrem D. MandelcornRahul N. KhuranaMohamed G. A. SalehPhoebe Lin, Lucia SobrinThomas A. Albini. (2018) OUTCOMES OF PARS PLANA VITRECTOMY FOR MACULAR HOLE IN PATIENTS WITH UVEITIS. Retina 38:1, pages S41-S48.
Crossref
Shree K. Kurup, Tanu Thomas & Howard F. Fine. (2017) Whether to Ignore the Macular Hole in a Uveitic Patient: A Discussion of the Pros and Cons of Elective Macular Surgery in a Challenging Population. Ophthalmic Surgery, Lasers and Imaging Retina 48:12, pages 956-960.
Crossref
Sara V. BransonBrendan R. McClaffertyShree K. Kurup. (2017) Vitrectomy for Epiretinal Membranes and Macular Holes in Uveitis Patients. Journal of Ocular Pharmacology and Therapeutics 33:4, pages 298-303.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.